217 related articles for article (PubMed ID: 33713000)
1. Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.
Goggi JL; Hartimath SV; Xuan TY; Khanapur S; Jieu B; Chin HX; Ramasamy B; Cheng P; Rong TJ; Fong YF; Yuen TY; Msallam R; Chacko AM; Renia L; Johannes C; Hwang YY; Robins EG
Mol Imaging Biol; 2021 Oct; 23(5):714-723. PubMed ID: 33713000
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes.
Goggi JL; Tan YX; Hartimath SV; Jieu B; Hwang YY; Jiang L; Boominathan R; Cheng P; Yuen TY; Chin HX; Tang JR; Larbi A; Chacko AM; Renia L; Johannes C; Robins EG
Mol Imaging Biol; 2020 Oct; 22(5):1392-1402. PubMed ID: 32705455
[TBL] [Abstract][Full Text] [Related]
3. Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model.
Hartimath SV; Ramasamy B; Xuan TY; Rong TJ; Khanapur S; Cheng P; Hwang YY; Robins EG; Goggi JL
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057046
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma.
Goggi JL; Ramasamy B; Tan YX; Hartimath SV; Tang JR; Cheng P; Msallam R; Chacko AM; Hwang YY; Robins EG
Mol Imaging; 2021; 2021():9305277. PubMed ID: 35936114
[TBL] [Abstract][Full Text] [Related]
5. Examining Immunotherapy Response Using Multiple Radiotracers.
Goggi JL; Hartimath SV; Hwang Y; Tan YX; Khanapur S; Ramasamy B; Jiang L; Yong FF; Cheng P; Tan PW; Husaini MA; Yuen TY; Jieu B; Chacko AM; Larbi A; Renia L; Johannes C; Robins EG
Mol Imaging Biol; 2020 Aug; 22(4):993-1002. PubMed ID: 32006204
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging.
Larimer BM; Bloch E; Nesti S; Austin EE; Wehrenberg-Klee E; Boland G; Mahmood U
Clin Cancer Res; 2019 Feb; 25(4):1196-1205. PubMed ID: 30327313
[TBL] [Abstract][Full Text] [Related]
7. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
8. A Novel Translational PET Imaging Approach to Quantifying Distal Tumor Immune Activation After Targeted Radiation Therapy and Checkpoint Blockade.
Zhang Y; Deshane JS; Yang ES; Larimer B
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1217-1227. PubMed ID: 38199384
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide.
de Aguiar Ferreira C; Heidari P; Ataeinia B; Sinevici N; Granito A; Kumar HM; Wehrenberg-Klee E; Mahmood U
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890355
[TBL] [Abstract][Full Text] [Related]
10. Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.
Pearson JD; Zhang J; Wu Z; Thew KD; Rowe KJ; Bacani JT; Ingham RJ
Mol Cancer; 2014 Aug; 13():199. PubMed ID: 25168906
[TBL] [Abstract][Full Text] [Related]
11. Granzyme B PET Imaging of the Innate Immune Response.
Capaccione KM; Doubrovin M; Bhatt N; Mintz A; Molotkov A
Molecules; 2020 Jul; 25(13):. PubMed ID: 32646038
[TBL] [Abstract][Full Text] [Related]
12. Monitoring CD8a
Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
[TBL] [Abstract][Full Text] [Related]
13. Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer.
Goggi JL; Khanapur S; Hartimath SV; Ramasamy B; Cheng P; Chin HX; Tang JR; Hwang YY; Robins EG
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289605
[TBL] [Abstract][Full Text] [Related]
14. Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response.
LaSalle T; Austin EE; Rigney G; Wehrenberg-Klee E; Nesti S; Larimer B; Mahmood U
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461343
[TBL] [Abstract][Full Text] [Related]
15. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
16. In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy.
Chen M; Zhou K; Dai SY; Tadepalli S; Balakrishnan PB; Xie J; Rami FEI; Dai T; Cui L; Idoyaga J; Rao J
Cell Chem Biol; 2022 Oct; 29(10):1556-1567.e6. PubMed ID: 36103874
[TBL] [Abstract][Full Text] [Related]
17. Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer.
Napier TS; Hunter CL; Song PN; Larimer BM; Sorace AG
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214172
[TBL] [Abstract][Full Text] [Related]
18. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.
Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z
Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956
[TBL] [Abstract][Full Text] [Related]
19. An Improved Synthesis of N-(4-[
Khanapur S; Yong FF; Hartimath SV; Jiang L; Ramasamy B; Cheng P; Narayanaswamy P; Goggi JL; Robins EG
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808813
[TBL] [Abstract][Full Text] [Related]
20. Granzyme B PET Imaging for Assessment of Disease Activity in Inflammatory Bowel Disease.
Heidari P; Haj-Mirzaian A; Prabhu S; Ataeinia B; Esfahani SA; Mahmood U
J Nucl Med; 2024 May; ():. PubMed ID: 38754959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]